Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Toothpaste showdown: which paste wins the cavity war?

NCT ID NCT07134231

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested three different toothpastes to see how well they prevent cavities. Thirty-six healthy adults wore a special dental device for six weeks, and researchers measured changes in enamel hardness. The goal was to find which toothpaste best protects teeth from decay.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

36 people

The number who actually took part.

Started

Oct 2025

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Potential subjects must meet ALL of the following criteria: * Males and females, between 18-70 years of age (inclusive); * Informed Consent Form signed and availability for the duration of the study; * Good general health (absence of any condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study. Examples include heart problems, valve/hip replacements, etc); * Willingness to provide information related to their medical history; * Minimum of 20 uncrowned permanent natural teeth (excluding third molars); Normal salivary flow; * Willingness to wear an intra-oral appliance all day as instructed except when eating and drinking. Exclusion Criteria: Potential subjects must NOT HAVE ANY of the following conditions: * Oral pathology, chronic disease, or a history of allergy to testing products; * Subject using anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory medication or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study; * Subject participating in any other clinical study; * Subject pregnant or breastfeeding; * Subject allergic to oral care products, personal care consumer products, or their ingredients; * Extended use of antibiotics or therapeutic mouthwash any time during the three months prior to entry into the study; * A medical history reporting that the subject has a current systemic or autoimmune disease, such as diabetes, lupus, etc.; * Ongoing use of medications known to affect the gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine); * Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone). Pocket depth equal or greater than 4 mm; * Five or more decayed, untreated dental sites (cavities); * Current smokers and subjects with a history of alcohol or drug abuse; * Dental work prevents wearing of the appliance or a reported need to wear a night guard.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Demineralization are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Federal University of Alagoas

    Maceió, Alagoas, 57072-970, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.